Moreover, IL-33 can also promote the infiltration of immunologic effector cells, such as NK cells, CD8+T cells, and TH1 immune cells and plays an anti-tumor role in several cancers (Fournié and Poupot, 2018; Sekiya et al, 2019). Here, CD8A is linked to cancer.